The Centers for Disease Control and Prevention (CDC) has increased by $44.25 million the Public Health Emergency Preparedness (PHEP) cooperative agreements for all-hazards preparedness efforts in 2016 and 2017. The funds will go to a total of 62 jurisdictions, including U.S. states, cities and territories.
The funds are part of the fiscal year 2016 Zika supplemental funding passed by Congress on Sept. 28, 2016, and signed by the president on Sept. 29, 2016. This increase restores PHEP funds previously redirected from states and other jurisdictions in March 2016 to support CDC’s Zika response.
"These CDC funds will enable states, cities, and territories to maintain and improve their routine preparedness and response efforts against a myriad of health threats,” said Stephen C. Redd, MD, director of CDC’s Office of Public Health Preparedness and Response. “We appreciate being able to make the PHEP-funded awardees whole again to continue their vital work preparing for and responding to natural disasters and disease outbreaks.”
Recipients will start receiving funding the week of October 17, 2016. They can use the funds to prepare for any type of public health emergency, including Zika.
The PHEP cooperative agreement is a critical source of funding for state, local, tribal, and territorial public health departments. Since 2002, the PHEP cooperative agreement has been the sole source of federal funding in support of public health emergency preparedness nationwide. In total, public health departments receive more than $9 billion to upgrade their ability to effectively respond to a range of public health threats, including infectious diseases; natural disasters; and biological, chemical, nuclear, and radiological events. Preparedness activities funded by the PHEP cooperative agreement are intended to help state and local public health departments develop flexible, adaptable response plans.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.